BioCentury | Jun 16, 2020
Finance
eTheRNA’s €34M series B to support different take on COVID-19 vaccine, build out core cancer pipeline
...in a series B round. The deal included new investors Grand Decade, a subsidiary of China Grand Pharmaceutical and Healthcare Holdings Ltd....